Artax Biopharma Inc

Looking for some stimulating summer reading? We’ve curated a selection of articles and resources that explore key themes in autoimmune-mediated conditions, skin health, and the evolving science of T cell modulation. Whether you’re poolside or enjoying a quiet moment indoors, take a deeper dive into the science that shapes our work at Artax. Read more below: 📘 Seven Principles for Healthy Skin │ Learn the fundamentals of skin health from the American Skin Association, Inc.—a great starting point for anyone looking to better understand and care for their skin: https://lnkd.in/e-JFvgua 📘 Expert Insights from AAD | Explore the American Academy of Dermatology’s public resource center for reliable, dermatologist-reviewed information on skin, hair, and nail care: https://www.aad.org/public 📘 Trusted Info at Your Fingertips │ Access easy-to-understand, expert-curated leaflets on a wide range of skin conditions by visiting the European Academy of Dermatology and Venereology site: https://bit.ly/4lVFwWU

This #FollowFriday, we’re spotlighting Prof. Thomas Bieber, MD, PhD, MDRA, a leading voice in #dermatology and #DrugDevelopment. As Scientific Director of the Medicine Programs at the Kühne Foundation, Dr. Bieber has pioneered key advances in our understanding of #AtopicDermatitis, including the role of immune dysregulation in disease progression. His work continues to shape the future of targeted therapies in dermatology. Follow Dr. Bieber for expert insights into skin inflammation and the evolving science driving therapeutic innovation.

Did you know, over 16 million adults in the U.S. are affected by #AtopicDermatitis, and nearly half of moderate-to-severe cases fail to achieve long-term control with current treatments? At Artax, we’re taking a new approach. Our #NckModulators are designed to target the underlying T-cell dysregulation that drives chronic inflammation to deliver durable relief without immunosuppression. Learn more about our approach: https://bit.ly/4ke4ijv

#UVSafetyAwarenessMonth is the perfect time to brush up on how to protect your skin from harmful #UV rays. The American Academy of Dermatology recommends these key tips: ☀️ Seek shade, especially between 10 a.m. and 2 p.m. 🧴 Use a broad-spectrum, water-resistant sunscreen with SPF 30+ and reapply every two hours 🧢 Wear protective clothing, like wide-brimmed hats and UV-blocking sunglasses Soak up the July sun in a safe way! Learn more: https://lnkd.in/eczHxHyk #PracticeSafeSun

#NationalLoveYourSkinDay is a moment to celebrate the skin we live in, across all skin tones and conditions, and to focus on the care it deserves every day. Skin health looks different for everyone, especially for those living with immune-mediated conditions like #psoriasis, where even brief daily exposure to natural sunlight can help ease symptoms and support healthier skin. Today, take a moment to protect, appreciate, and love the skin you’re in.

This #UVSafetyAwarenessMonth, we’re spotlighting the importance of protecting your skin from harmful #UV rays—one of the leading causes of skin cancer. As highlighted by the World Health Organization, simple habits like applying SPF, seeking shade, and wearing protective clothing can make a big difference. We're advancing a new class of therapies, #NckModulators, that have the potential to restore the immune balance by enabling immunomodulation without immunosuppression across many dermatologic conditions. As we spotlight UV Safety Month, we're proud to support both external protection and internal innovation for healthier skin and stronger immunity. Learn more about UV safety: https://bit.ly/3Gfx4lM

This #FollowFriday, we're spotlighting Melinda Gooderham, MSc, MD, FRCPC, a valued leader in the dermatology space. With a multitude of experience as a Physician at SKiN Health, Clinical Researcher, and Assistant Professor, Dr. Gooderham is spearheading innovative approaches to treating inflammatory diseases, including #AtopicDermatitis, #Psoriasis, #HidradenitisSuppurativa, and other immunologically-driven diseases. Follow Dr. Gooderham for more information on dermatology and inflammatory diseases.

We want to extend a warm congratulations to our founder, Balbino Alarcon, PhD, on being a co-recipient of the prestigious 19th Francisco Cobos Foundation Award by CSIC! Dr. Alarcón was recognized for his pioneering work elucidating foundational T-cell receptor (TCR) biology including its interaction with the adaptor protein Nck. This breakthrough has laid the foundation for the development of our first-in-class Nck inhibitors to modulate TCR activation and potentially address a broad range of #AutoimmuneDiseases. We are incredibly thankful for Dr. Alarcón's leadership and vision as we continue advancing our mission to deliver transformative therapies! Read more here: https://bit.ly/3T6QeNE

We had a wonderful time at #BIO2025 highlighting our platform's potential in targeting #AutoimmuneDiseases. Thank you for the engaging conversations and opportunity to connect with industry peers! Biotechnology Innovation Organization

#AtopicDermatitis is a chronic skin condition that affects 1 in 10 people in their lifetime. For many, the persistent itch-scratch cycle can significantly impact quality of life. At Artax, we’re committed to developing therapies that address this unmet need. Our #ClinicalTrials aim to advance treatments that target T cell activation without causing immunosuppression. Learn more about our developing pipeline: https://lnkd.in/d_RrncBp